Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00137514Phase 4Completed
Phase 4, randomised, open-label trial of amodiaquine and chloroquine in Falciparum malaria (PF) (4 arms), sponsored by Bandim Health Project. Primary endpoints: Parasite reappearance rate at Day 35 and Hospitalization during follow-up at Day 35. Started Mar 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00137514.